Bioequivalence Study without approved/marketed or no RLD [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-13 11:01 (1938 d 07:24 ago) – Posting: # 21263
Views: 2,821

Hello,

If the RLD is unavailable in your country (yet to get register), how would the generic market itself? In EU and middle East, the RLD has to be registered in the target market for the generic to get a chance based on BE. It could be different in China.

What I understand from your draft is that you are the CRO. If sponsor gives you the RLD and test article you can go for pK based study.

Cheers, SKM

Complete thread:

UA Flag
Activity
 Admin contact
23,426 posts in 4,929 threads, 1,681 registered users;
18 visitors (0 registered, 18 guests [including 7 identified bots]).
Forum time: 19:26 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5